{"formats":[{"name":"JSON","format":"json","url":"\/downloads\/2025\/code-json\/38.2-3562.json"},{"name":"Plain Text","format":"text","url":"\/downloads\/2025\/code-text\/38.2-3562.txt"},{"name":"XML","format":"xml","url":"\/downloads\/2025\/code-xml\/38.2-3562.xml"},{"name":"HTML","format":"html","url":"\/downloads\/2025\/code-html\/38.2-3562.html"}],"law_id":83961,"edition_id":1,"section_id":83961,"structure_id":14588,"section_number":"38.2-3562","catch_line":"Expedited external review","history":"2011, c. 788; 2019, cc. 826, 840.","full_text":"A\n\nA covered person or his authorized representative may make a request for an expedited external review with the Commission at the time the covered person receives:1\n\nAn adverse determination if the adverse determination involves (i) cancer or (ii) a medical condition of the covered person for which the time frame for completion of an expedited internal appeal involving an adverse determination would seriously jeopardize the life or health of the covered person or would jeopardize the covered person’s ability to regain maximum function, and the covered person or his authorized representative has filed a request for an expedited internal appeal of the adverse determination; or2\n\nA final adverse determination if the covered person has (i) cancer or (ii) a medical condition where the time frame for completion of a standard external review would seriously jeopardize the life or health of the covered person or would jeopardize the covered person’s ability to regain maximum function, or if the final adverse determination concerns an admission, availability of care, continued stay, or health care service for which the covered person received emergency services, but has not been discharged from a facility.B\n\nUpon receipt of a request for an expedited external review, the Commission shall promptly send a copy of the request to the health carrier. Promptly upon receipt of such request, the health carrier shall determine whether the request meets the eligibility requirements in subsection B of § 38.2-3561. The health carrier shall promptly notify the Commission, the covered person, and his authorized representative, if any, of its eligibility determination. Such notice shall include a statement informing the covered person and his authorized representative, if any, that the health carrier’s determination of ineligibility may be appealed to the Commission. If the health carrier makes an ineligibility determination, the Commission may determine that a request is eligible for external review and require that it be referred for external review. In making such determination, the Commission decision shall be made in accordance with the terms of the covered person’s health benefit plan and the requirements of subsection B of § 38.2-3561.\n\t\t\tUpon receipt of the notice that the request meets the eligibility requirements, the Commission shall promptly assign an independent review organization to conduct the expedited external review. The Commission shall promptly notify the health carrier of the name of the assigned independent review organization.C\n\nPromptly upon receipt of the notice from the Commission of the name of the independent review organization assigned, the health carrier or its designee utilization review entity shall provide or transmit all necessary documents and information considered in making the adverse determination or final adverse determination to the assigned independent review organization electronically, by telephone, facsimile, or any other available expeditious method.D\n\nThe assigned independent review organization, to the extent the information or documents are available and the independent review organization considers them appropriate, shall also consider the following in reaching a decision:1\n\nThe covered person’s pertinent medical records;2\n\nThe attending health care professional’s recommendation;3\n\nConsulting reports from appropriate health care professionals and other documents submitted by the health carrier, covered person, his authorized representative, or the covered person’s treating provider;4\n\nThe terms of coverage under the covered person’s health benefit plan;5\n\nThe most appropriate practice guidelines, which shall include evidence-based standards, and may include any other practice guidelines developed by the federal government or national or professional medical societies, boards, and associations;6\n\nAny applicable clinical review criteria developed and used by the health carrier or its designee utilization review entity in making adverse determinations; and7\n\nThe opinion of the independent review organization’s clinical reviewer or reviewers after considering the information and documents described in clauses 1 through 6 to the extent the information and documents are available and the clinical reviewer or reviewers consider appropriate.\n\t\t\t\tIn reaching a decision, the assigned independent review organization is not bound by any decisions or conclusions reached during the health carrier’s utilization review process or internal appeal process.E\n\nAs expeditiously as the covered person’s medical condition or circumstances requires, but in no event more than 72 hours after the date of receipt of an eligible request for an expedited external review, the assigned independent review organization shall make a decision to uphold or reverse the adverse determination or final adverse determination and notify the covered person, his authorized representative, if any, the health carrier, and the Commission. If such decision was not in writing, within 48 hours after the date of providing such decision, the assigned independent review organization shall provide written confirmation of the decision to the covered person, his authorized representative, if any, the health carrier, and the Commission and include the information set forth in subsection I of § 38.2-3561.F\n\nUpon receipt of a decision reversing the adverse determination or final adverse determination, the health carrier shall promptly approve the coverage.G\n\nAn expedited external review shall not be available for retrospective adverse determinations or retrospective final adverse determinations.","order_by":null,"text":{"0":{"id":300893,"text":"A covered person or his authorized representative may make a request for an expedited external review with the Commission at the time the covered person receives:","type":"section","prefixes":["A"],"prefix":"A","entire_prefix":"A","prefix_anchor":"A","level":1,"next_prefix":"A1"},"1":{"id":300894,"text":"An adverse determination if the adverse determination involves (i) cancer or (ii) a medical condition of the covered person for which the time frame for completion of an expedited internal appeal involving an adverse determination would seriously jeopardize the life or health of the covered person or would jeopardize the covered person’s ability to regain maximum function, and the covered person or his authorized representative has filed a request for an expedited internal appeal of the adverse determination; or","type":"section","prefixes":["A","1"],"prefix":"1","entire_prefix":"A1","prefix_anchor":"A1","level":2,"prior_prefix":"A","next_prefix":"A2"},"2":{"id":300895,"text":"A final adverse determination if the covered person has (i) cancer or (ii) a medical condition where the time frame for completion of a standard external review would seriously jeopardize the life or health of the covered person or would jeopardize the covered person’s ability to regain maximum function, or if the final adverse determination concerns an admission, availability of care, continued stay, or health care service for which the covered person received emergency services, but has not been discharged from a facility.","type":"section","prefixes":["A","2"],"prefix":"2","entire_prefix":"A2","prefix_anchor":"A2","level":2,"prior_prefix":"A1","next_prefix":"B"},"3":{"id":300896,"text":"Upon receipt of a request for an expedited external review, the Commission shall promptly send a copy of the request to the health carrier. Promptly upon receipt of such request, the health carrier shall determine whether the request meets the eligibility requirements in subsection B of § 38.2-3561. The health carrier shall promptly notify the Commission, the covered person, and his authorized representative, if any, of its eligibility determination. Such notice shall include a statement informing the covered person and his authorized representative, if any, that the health carrier’s determination of ineligibility may be appealed to the Commission. If the health carrier makes an ineligibility determination, the Commission may determine that a request is eligible for external review and require that it be referred for external review. In making such determination, the Commission decision shall be made in accordance with the terms of the covered person’s health benefit plan and the requirements of subsection B of § 38.2-3561.\n\t\t\tUpon receipt of the notice that the request meets the eligibility requirements, the Commission shall promptly assign an independent review organization to conduct the expedited external review. The Commission shall promptly notify the health carrier of the name of the assigned independent review organization.","type":"section","prefixes":["B"],"prefix":"B","entire_prefix":"B","prefix_anchor":"B","level":1,"prior_prefix":"A2","next_prefix":"C"},"4":{"id":300897,"text":"Promptly upon receipt of the notice from the Commission of the name of the independent review organization assigned, the health carrier or its designee utilization review entity shall provide or transmit all necessary documents and information considered in making the adverse determination or final adverse determination to the assigned independent review organization electronically, by telephone, facsimile, or any other available expeditious method.","type":"section","prefixes":["C"],"prefix":"C","entire_prefix":"C","prefix_anchor":"C","level":1,"prior_prefix":"B","next_prefix":"D"},"5":{"id":300898,"text":"The assigned independent review organization, to the extent the information or documents are available and the independent review organization considers them appropriate, shall also consider the following in reaching a decision:","type":"section","prefixes":["D"],"prefix":"D","entire_prefix":"D","prefix_anchor":"D","level":1,"prior_prefix":"C","next_prefix":"D1"},"6":{"id":300899,"text":"The covered person’s pertinent medical records;","type":"section","prefixes":["D","1"],"prefix":"1","entire_prefix":"D1","prefix_anchor":"D1","level":2,"prior_prefix":"D","next_prefix":"D2"},"7":{"id":300900,"text":"The attending health care professional’s recommendation;","type":"section","prefixes":["D","2"],"prefix":"2","entire_prefix":"D2","prefix_anchor":"D2","level":2,"prior_prefix":"D1","next_prefix":"D3"},"8":{"id":300901,"text":"Consulting reports from appropriate health care professionals and other documents submitted by the health carrier, covered person, his authorized representative, or the covered person’s treating provider;","type":"section","prefixes":["D","3"],"prefix":"3","entire_prefix":"D3","prefix_anchor":"D3","level":2,"prior_prefix":"D2","next_prefix":"D4"},"9":{"id":300902,"text":"The terms of coverage under the covered person’s health benefit plan;","type":"section","prefixes":["D","4"],"prefix":"4","entire_prefix":"D4","prefix_anchor":"D4","level":2,"prior_prefix":"D3","next_prefix":"D5"},"10":{"id":300903,"text":"The most appropriate practice guidelines, which shall include evidence-based standards, and may include any other practice guidelines developed by the federal government or national or professional medical societies, boards, and associations;","type":"section","prefixes":["D","5"],"prefix":"5","entire_prefix":"D5","prefix_anchor":"D5","level":2,"prior_prefix":"D4","next_prefix":"D6"},"11":{"id":300904,"text":"Any applicable clinical review criteria developed and used by the health carrier or its designee utilization review entity in making adverse determinations; and","type":"section","prefixes":["D","6"],"prefix":"6","entire_prefix":"D6","prefix_anchor":"D6","level":2,"prior_prefix":"D5","next_prefix":"D7"},"12":{"id":300905,"text":"The opinion of the independent review organization’s clinical reviewer or reviewers after considering the information and documents described in clauses 1 through 6 to the extent the information and documents are available and the clinical reviewer or reviewers consider appropriate.\n\t\t\t\tIn reaching a decision, the assigned independent review organization is not bound by any decisions or conclusions reached during the health carrier’s utilization review process or internal appeal process.","type":"section","prefixes":["D","7"],"prefix":"7","entire_prefix":"D7","prefix_anchor":"D7","level":2,"prior_prefix":"D6","next_prefix":"E"},"13":{"id":300906,"text":"As expeditiously as the covered person’s medical condition or circumstances requires, but in no event more than 72 hours after the date of receipt of an eligible request for an expedited external review, the assigned independent review organization shall make a decision to uphold or reverse the adverse determination or final adverse determination and notify the covered person, his authorized representative, if any, the health carrier, and the Commission. If such decision was not in writing, within 48 hours after the date of providing such decision, the assigned independent review organization shall provide written confirmation of the decision to the covered person, his authorized representative, if any, the health carrier, and the Commission and include the information set forth in subsection I of § 38.2-3561.","type":"section","prefixes":["E"],"prefix":"E","entire_prefix":"E","prefix_anchor":"E","level":1,"prior_prefix":"D7","next_prefix":"F"},"14":{"id":300907,"text":"Upon receipt of a decision reversing the adverse determination or final adverse determination, the health carrier shall promptly approve the coverage.","type":"section","prefixes":["F"],"prefix":"F","entire_prefix":"F","prefix_anchor":"F","level":1,"prior_prefix":"E","next_prefix":"G"},"15":{"id":300908,"text":"An expedited external review shall not be available for retrospective adverse determinations or retrospective final adverse determinations.","type":"section","prefixes":["G"],"prefix":"G","entire_prefix":"G","prefix_anchor":"G","level":1,"prior_prefix":"F"}},"ancestry":[{"id":14588,"edition_id":1,"name":"Health Carrier Internal Appeal Process and External Review","identifier":"35.1","label":"chapter","depth":2,"order_by":1,"parent_id":12698,"metadata":{},"date_created":"2026-06-26 03:48:47","date_modified":"2026-06-26 03:48:47","permalink":{"id":215937,"object_type":"structure","relational_id":14588,"identifier":"35.1","token":"38.2\/35.1","url":"\/38.2\/35.1\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12698,"edition_id":1,"name":"Insurance","identifier":"38.2","label":"title","depth":1,"order_by":1,"parent_id":null,"metadata":{},"date_created":"2026-06-26 03:43:49","date_modified":"2026-06-26 03:43:49","permalink":{"id":210661,"object_type":"structure","relational_id":12698,"identifier":"38.2","token":"38.2","url":"\/38.2\/","edition_id":1,"permalink":0,"preferred":1}}],"structure_contents":[{"id":58140,"structure_id":14588,"section_number":"38.2-3556","catch_line":"Definitions","url":"\/38.2-3556\/","token":"38.2\/35.1\/38.2-3556","metadata":false},{"id":56086,"structure_id":14588,"section_number":"38.2-3557","catch_line":"Scope of chapter","url":"\/38.2-3557\/","token":"38.2\/35.1\/38.2-3557","metadata":false},{"id":56843,"structure_id":14588,"section_number":"38.2-3558","catch_line":"Health carrier's internal appeal process","url":"\/38.2-3558\/","token":"38.2\/35.1\/38.2-3558","metadata":false},{"id":77920,"structure_id":14588,"section_number":"38.2-3559","catch_line":"Notice of right to external review","url":"\/38.2-3559\/","token":"38.2\/35.1\/38.2-3559","metadata":false},{"id":65207,"structure_id":14588,"section_number":"38.2-3560","catch_line":"Exhaustion of internal appeal process","url":"\/38.2-3560\/","token":"38.2\/35.1\/38.2-3560","metadata":false},{"id":66856,"structure_id":14588,"section_number":"38.2-3561","catch_line":"Standard external review","url":"\/38.2-3561\/","token":"38.2\/35.1\/38.2-3561","metadata":false},{"id":83961,"structure_id":14588,"section_number":"38.2-3562","catch_line":"Expedited external review","url":"\/38.2-3562\/","token":"38.2\/35.1\/38.2-3562","metadata":false},{"id":63745,"structure_id":14588,"section_number":"38.2-3563","catch_line":"External review of experimental or investigational treatment adverse determinations","url":"\/38.2-3563\/","token":"38.2\/35.1\/38.2-3563","metadata":false},{"id":78633,"structure_id":14588,"section_number":"38.2-3564","catch_line":"Binding nature of external review decision","url":"\/38.2-3564\/","token":"38.2\/35.1\/38.2-3564","metadata":false},{"id":63044,"structure_id":14588,"section_number":"38.2-3565","catch_line":"Minimum qualifications for independent review organizations","url":"\/38.2-3565\/","token":"38.2\/35.1\/38.2-3565","metadata":false},{"id":59040,"structure_id":14588,"section_number":"38.2-3566","catch_line":"Approval of independent review organizations","url":"\/38.2-3566\/","token":"38.2\/35.1\/38.2-3566","metadata":false},{"id":79665,"structure_id":14588,"section_number":"38.2-3567","catch_line":"Independent review organizations to be held harmless","url":"\/38.2-3567\/","token":"38.2\/35.1\/38.2-3567","metadata":false},{"id":81396,"structure_id":14588,"section_number":"38.2-3568","catch_line":"External review reporting requirements","url":"\/38.2-3568\/","token":"38.2\/35.1\/38.2-3568","metadata":false},{"id":75481,"structure_id":14588,"section_number":"38.2-3569","catch_line":"Funding of external review","url":"\/38.2-3569\/","token":"38.2\/35.1\/38.2-3569","metadata":false},{"id":83489,"structure_id":14588,"section_number":"38.2-3570","catch_line":"Disclosure requirements","url":"\/38.2-3570\/","token":"38.2\/35.1\/38.2-3570","metadata":false},{"id":56157,"structure_id":14588,"section_number":"38.2-3571","catch_line":"Regulations","url":"\/38.2-3571\/","token":"38.2\/35.1\/38.2-3571","metadata":false}],"previous_section":{"id":66856,"structure_id":14588,"section_number":"38.2-3561","catch_line":"Standard external review","url":"\/38.2-3561\/","token":"38.2\/35.1\/38.2-3561","metadata":false},"next_section":{"id":63745,"structure_id":14588,"section_number":"38.2-3563","catch_line":"External review of experimental or investigational treatment adverse determinations","url":"\/38.2-3563\/","token":"38.2\/35.1\/38.2-3563","metadata":false},"metadata":false,"official_url":"https:\/\/law.lis.virginia.gov\/vacode\/38.2-3562\/","history_text":"

This law was first created in 2011. The record of its establishment is cataloged in chapter 788<\/a> of that year\u2019s edition of \u201cActs of Assembly,\u201d the annual state publication listing all changes made to the Code of Virginia in that year. It has been modified 1 time. Those modifications are cataloged by \u201cThe Acts of Assembly,\u201d a state publication, by year and chapter. Those modifications that can be read on the General Assembly\u2019s website will be linked accordingly. That modification is as follows: in 2019, chapters 826<\/a> and 840<\/a>.<\/p>","references":[{"id":77920,"section_number":"38.2-3559","catch_line":"Notice of right to external review","order_by":null,"url":"\/38.2-3559\/"}],"refers_to":[{"id":66856,"section_number":"38.2-3561","catch_line":"Standard external review","order_by":null,"url":"\/38.2-3561\/"}],"permalink":{"id":215963,"object_type":"law","relational_id":83961,"identifier":"38.2-3562","token":"38.2\/35.1\/38.2-3562","url":"\/38.2-3562\/","edition_id":1,"permalink":0,"preferred":1},"url":"\/38.2-3562\/","token":"38.2\/35.1\/38.2-3562","dublin_core":{"Title":"Expedited external review","Type":"Text","Format":"text\/html","Identifier":"\u00a7 38.2-3562","Relation":"Code of Virginia"},"html":"\n\t\t\t\t\t\t

A.<\/span> A covered person<\/span> or his authorized representative<\/span> may make a request for an expedited external review with the Commission<\/span> at the time the covered person<\/span> receives: <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

1.<\/span> An adverse determination<\/span> if the adverse determination<\/span> involves (i) cancer or (ii) a medical condition of the covered person<\/span> for which the time frame for completion of an expedited internal appeal<\/span> involving an adverse determination<\/span> would seriously jeopardize the life or health of the covered person<\/span> or would jeopardize the covered person<\/span>’s ability to regain maximum function, and the covered person<\/span> or his authorized representative<\/span> has filed a request for an expedited internal appeal<\/span> of the adverse determination<\/span>; or <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

2.<\/span> A final adverse determination<\/span> if the covered person<\/span> has (i) cancer or (ii) a medical condition where the time frame for completion of a standard external review would seriously jeopardize the life or health of the covered person<\/span> or would jeopardize the covered person<\/span>’s ability to regain maximum function, or if the final adverse determination<\/span> concerns an admission, availability of care, continued stay<\/span>, or health care service for which the covered person<\/span> received emergency services<\/span>, but has not been discharged from a facility<\/span>. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

B.<\/span> Upon receipt of a request for an expedited external review, the Commission<\/span> shall promptly send a copy of the request to the health carrier<\/span>. Promptly upon receipt of such request, the health carrier<\/span> shall determine whether the request meets the eligibility requirements in subsection B of § 38.2-3561<\/a>. The health carrier<\/span> shall promptly notify the Commission<\/span>, the covered person<\/span>, and his authorized representative<\/span>, if any, of its eligibility determination. Such notice shall include a statement informing the covered person<\/span> and his authorized representative<\/span>, if any, that the health carrier<\/span>’s determination of ineligibility may be appealed to the Commission<\/span>. If the health carrier<\/span> makes an ineligibility determination, the Commission<\/span> may determine that a request is eligible for external review and require that it be referred for external review. In making such determination, the Commission<\/span> decision shall be made in accordance with the terms of the covered person<\/span>’s health benefit plan<\/span> and the requirements of subsection B of § 38.2-3561<\/a>.\n\t\t\tUpon receipt of the notice that the request meets the eligibility requirements, the Commission<\/span> shall promptly assign an independent review organization<\/span> to conduct the expedited external review. The Commission<\/span> shall promptly notify the health carrier<\/span> of the name of the assigned independent review organization<\/span>. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

C.<\/span> Promptly upon receipt of the notice from the Commission<\/span> of the name of the independent review organization<\/span> assigned, the health carrier<\/span> or its designee utilization review entity<\/span> shall provide or transmit all necessary documents and information considered in making the adverse determination or final adverse determination<\/span> to the assigned independent review organization<\/span> electronically, by telephone, facsimile, or any other available expeditious method. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

D.<\/span> The assigned independent review organization<\/span>, to the extent the information or documents are available and the independent review organization<\/span> considers them appropriate, shall also consider the following in reaching a decision: <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

1.<\/span> The covered person<\/span>’s pertinent medical records; <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

2.<\/span> The attending health care professional<\/span>’s recommendation; <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

3.<\/span> Consulting reports from appropriate health care professionals<\/span> and other documents submitted by the health carrier<\/span>, covered person<\/span>, his authorized representative<\/span>, or the covered person<\/span>’s treating provider<\/span>; <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

4.<\/span> The terms of coverage under the covered person<\/span>’s health benefit plan<\/span>; <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

5.<\/span> The most appropriate practice guidelines, which shall include evidence<\/span>-based standards<\/span>, and may include any other practice guidelines developed by the federal government or national or professional medical societies, boards, and associations; <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

6.<\/span> Any applicable clinical review criteria<\/span> developed and used by the health carrier<\/span> or its designee utilization review entity<\/span> in making adverse determinations<\/span>; and <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

7.<\/span> The opinion<\/span> of the independent review organization<\/span>’s clinical reviewer or reviewers after considering the information and documents described in clauses 1 through 6 to the extent the information and documents are available and the clinical reviewer or reviewers consider appropriate.\n\t\t\t\tIn reaching a decision, the assigned independent review organization<\/span> is not bound by any decisions or conclusions reached during the health carrier<\/span>’s utilization review process or internal appeal<\/span> process. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

E.<\/span> As expeditiously as the covered person<\/span>’s medical condition or circumstances requires, but in no event more than 72 hours after the date of receipt of an eligible request for an expedited external review, the assigned independent review organization<\/span> shall make a decision to uphold<\/span> or reverse<\/span> the adverse determination or final adverse determination<\/span> and notify the covered person<\/span>, his authorized representative<\/span>, if any, the health carrier<\/span>, and the Commission<\/span>. If such decision was not in writing, within 48 hours after the date of providing such decision, the assigned independent review organization<\/span> shall provide written confirmation of the decision to the covered person<\/span>, his authorized representative<\/span>, if any, the health carrier<\/span>, and the Commission<\/span> and include the information set forth in subsection I of § 38.2-3561<\/a>. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

F.<\/span> Upon receipt of a decision reversing the adverse determination or final adverse determination<\/span>, the health carrier<\/span> shall promptly approve the coverage. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

G.<\/span> An expedited external review shall not be available for retrospective adverse determinations or retrospective final adverse determinations<\/span>. <\/i><\/a><\/p><\/section>","plain_text":" CODE OF VIRGINIA\n\nEXPEDITED EXTERNAL REVIEW (\u00a7 38.2-3562)\n\nA. A covered person or his authorized representative may make a request for an\nexpedited external review with the Commission at the time the covered person\nreceives:\n\n 1. An adverse determination if the adverse determination involves (i) cancer\n or (ii) a medical condition of the covered person for which the time frame for\n completion of an expedited internal appeal involving an adverse determination\n would seriously jeopardize the life or health of the covered person or would\n jeopardize the covered person’s ability to regain maximum function, and\n the covered person or his authorized representative has filed a request for an\n expedited internal appeal of the adverse determination; or\n\n 2. A final adverse determination if the covered person has (i) cancer or (ii)\n a medical condition where the time frame for completion of a standard external\n review would seriously jeopardize the life or health of the covered person or\n would jeopardize the covered person’s ability to regain maximum\n function, or if the final adverse determination concerns an admission,\n availability of care, continued stay, or health care service for which the\n covered person received emergency services, but has not been discharged from a\n facility.\n\nB. Upon receipt of a request for an expedited external review, the Commission\nshall promptly send a copy of the request to the health carrier. Promptly upon\nreceipt of such request, the health carrier shall determine whether the request\nmeets the eligibility requirements in subsection B of § 38.2-3561. The\nhealth carrier shall promptly notify the Commission, the covered person, and his\nauthorized representative, if any, of its eligibility determination. Such notice\nshall include a statement informing the covered person and his authorized\nrepresentative, if any, that the health carrier’s determination of\nineligibility may be appealed to the Commission. If the health carrier makes an\nineligibility determination, the Commission may determine that a request is\neligible for external review and require that it be referred for external\nreview. In making such determination, the Commission decision shall be made in\naccordance with the terms of the covered person’s health benefit plan and\nthe requirements of subsection B of § 38.2-3561.\n\t\t\tUpon receipt of the notice that the request meets the eligibility\nrequirements, the Commission shall promptly assign an independent review\norganization to conduct the expedited external review. The Commission shall\npromptly notify the health carrier of the name of the assigned independent\nreview organization.\n\nC. Promptly upon receipt of the notice from the Commission of the name of the\nindependent review organization assigned, the health carrier or its designee\nutilization review entity shall provide or transmit all necessary documents and\ninformation considered in making the adverse determination or final adverse\ndetermination to the assigned independent review organization electronically, by\ntelephone, facsimile, or any other available expeditious method.\n\nD. The assigned independent review organization, to the extent the information\nor documents are available and the independent review organization considers\nthem appropriate, shall also consider the following in reaching a decision:\n\n 1. The covered person’s pertinent medical records;\n\n 2. The attending health care professional’s recommendation;\n\n 3. Consulting reports from appropriate health care professionals and other\n documents submitted by the health carrier, covered person, his authorized\n representative, or the covered person’s treating provider;\n\n 4. The terms of coverage under the covered person’s health benefit plan;\n\n 5. The most appropriate practice guidelines, which shall include\n evidence-based standards, and may include any other practice guidelines\n developed by the federal government or national or professional medical\n societies, boards, and associations;\n\n 6. Any applicable clinical review criteria developed and used by the health\n carrier or its designee utilization review entity in making adverse\n determinations; and\n\n 7. The opinion of the independent review organization’s clinical\n reviewer or reviewers after considering the information and documents\n described in clauses 1 through 6 to the extent the information and documents\n are available and the clinical reviewer or reviewers consider appropriate.\n \t\t\t\tIn reaching a decision, the assigned independent review organization is\n not bound by any decisions or conclusions reached during the health\n carrier’s utilization review process or internal appeal process.\n\nE. As expeditiously as the covered person’s medical condition or\ncircumstances requires, but in no event more than 72 hours after the date of\nreceipt of an eligible request for an expedited external review, the assigned\nindependent review organization shall make a decision to uphold or reverse the\nadverse determination or final adverse determination and notify the covered\nperson, his authorized representative, if any, the health carrier, and the\nCommission. If such decision was not in writing, within 48 hours after the date\nof providing such decision, the assigned independent review organization shall\nprovide written confirmation of the decision to the covered person, his\nauthorized representative, if any, the health carrier, and the Commission and\ninclude the information set forth in subsection I of § 38.2-3561.\n\nF. Upon receipt of a decision reversing the adverse determination or final\nadverse determination, the health carrier shall promptly approve the coverage.\n\nG. An expedited external review shall not be available for retrospective adverse\ndeterminations or retrospective final adverse determinations.\n\nHISTORY: 2011, c. 788; 2019, cc. 826, 840.","edition":{"id":1,"name":"2025","slug":"2025","date_created":"2026-06-21 22:39:22","date_modified":"2026-06-21 22:39:22","current":1,"order_by":1,"last_import":null}}